Accumulus Technologies Launches Connector for Real-Time Regulatory Collaboration

SAN FRANCISCO, March 24, 2026 – Accumulus Technologies today announced the launch of the Accumulus Connector, a new platform capability designed to streamline regulatory processes for pharmaceutical and biotech companies. The Connector facilitates live integration with regulatory systems, enabling real-time data exchange and collaboration with over 70 national regulatory authorities worldwide.

Addressing the Challenges of Regulatory Complexity

The pharmaceutical and biotechnology industries face increasing complexity in navigating global regulatory landscapes. Traditional methods of submitting data and communicating with regulatory bodies are often fragmented, manual, and time-consuming. The Accumulus Connector aims to resolve these issues by providing a direct, real-time channel for regulatory collaboration.

How the Accumulus Connector Works

The Accumulus Connector extends the existing Accumulus platform into customers’ current technology infrastructure. This allows for bidirectional data flow between a company’s systems of record and regulatory authorities, eliminating the need for manual data reconciliation. According to Accumulus Technologies, the Connector is built to integrate seamlessly with both current and future technology stacks.

Key Benefits of the Accumulus Connector

• Accelerated Submissions: Enables “one-click global submissions” by connecting systems directly to regulators.
• Real-Time Collaboration: Fosters continuous, real-time collaboration across integrated systems.
• Reduced Manual Effort: Eliminates manual data reconciliation, improving efficiency and reducing errors.
• Unified Regulatory Environment: Creates a unified, always-on regulatory environment for streamlined processes.
• Scalability: Provides a scalable foundation for a more connected and future-proof regulatory environment.

Industry and Regulatory Perspectives

Francisco Nogueira, CEO of Accumulus Technologies, stated that the Connector represents “a turning point for accelerated regulatory collaboration.” A representative from a leading health authority highlighted the potential to reduce regulatory duplication and increase transparency, potentially leading to faster access to vital medications globally.

Expanding the Regulatory Ecosystem

The Accumulus Connector isn’t just for industry; it also allows regulators to connect their own systems directly to the Accumulus platform. This creates a bidirectional network, fostering greater collaboration and efficiency across the entire regulatory ecosystem.

About Accumulus Technologies

Accumulus Technologies is a cloud technology provider focused on reimagining collaboration between life sciences organizations and national regulatory authorities. The company was spun out of the nonprofit Accumulus Synergy in 2025 and offers a SaaS platform designed to accelerate the drug development lifecycle.

Availability

The Accumulus Connector is currently available to subscribers of the Accumulus platform.